can i use my hsa card for semaglutide FSA or Funds Your Weight Loss & Peptide Programs Compounded Semaglutide for Weight Loss

News provided by Eli Lilly and Company Jul 23, 2026, 06:45 ET In TRIUMPH-2, adults with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost up to an average of 49.6 lbs (20.8%) at 80 weeks In TRIUMPH-3, adults with severe obesity and established cardiovascular disease, with or without type 2 diabetes, lost up to an average of 55.8 lbs (22.6%) at 80 weeks Lilly plans to submit a Biologics License Application (BLA) for retatrutide to FDA in Q1 2027 INDIANAPOLIS, July 23, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-2 and TRIUMPH-3, two pivotal Phase 3 trials evaluating retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist

Thyroid cancer history As discussed, cagrilintide is contraindicated in individuals with personal or family history of medullary thyroid carcinoma or MEN2

Rybelsus, an oral version of semaglutide, was initially designed for type 2 diabetes but has shown promise for weight loss, particularly in clinical trials

Epithelial and epidermal growth factors are equally important for skin health, as their names imply

Peptide vials are used for administration by subcutaneous injections once reconstituted